1-5 of 5
Paul K. Wallace, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Emergence of Rituximab-Fludarabine Resistance Is Associated with Changes in CD20 Antigen Expression and Improved Response to Almetuzumab Therapy in Patients with Chronic Lymphocytic Leukemia (CLL).

Umeer Ashraf, MD, Anjana N. Elefante, PharmD, Raymond Cruz, MD, Paul K. Wallace, PhD, Myron S. Czuczman, MD, Francisco J. Hernandez-llizaliturri, MD
Journal: Blood
Blood (2007) 110 (11): 2054.
https://doi.org/10.1182/blood.V110.11.2054.2054
Published: 2007
Journal Articles

Long-Term Outcome of Cyclosporin A Therapy for T-Cell Large Granular Lymphocyte Leukemia.

Attaphol Pawarode, MD, Paul K. Wallace, PhD, Laurie A. Ford, BS, Maurice Barcos, MD, PhD, Maria R. Baer, MD
Journal: Blood
Blood (2007) 110 (11): 2063.
https://doi.org/10.1182/blood.V110.11.2063.2063
Published: 2007
Journal Articles

Frequent Molecular Aberrations in Normal Karyotype (NC) Precursor B-Cell Acute Lymphoblastic Leukemia (pB-ALL) Detected by Comparative Genomic Hybridization.

Amer Zeidan, MD, Dan Gaile, PhD, Jeffrey M. Conroy, MS, Devin E. McQuaid, MS, Eunice S. Wang, MD, George Deeb, MD, Paul K. Wallace, PhD, Sheila N.J. Sait, PhD, Norma J. Nowak, PhD, Meir Wetzler, MD
Journal: Blood
Blood (2007) 110 (11): 4270.
https://doi.org/10.1182/blood.V110.11.4270.4270
Published: 2007
Journal Articles

Randomized Trial of GM-CSF and G-CSF Following High-Dose Cytarabine and Mitoxantrone Chemotherapy for Relapsed and Refractory Acute Leukemia.

Maria R. Baer, MD, Laurie A. Ford, BS, Brian N. Bundy, PhD, Sheila M. Tighe, BS, Kieran L. O’Loughlin, MS, James L. Slack, MD, Meir Wetzler, MD, Paul K. Wallace, PhD
Journal: Blood
Blood (2006) 108 (11): 4574.
https://doi.org/10.1182/blood.V108.11.4574.4574
Published: 2006
Journal Articles

Efficacy and Safety of the Combination of Genasense™ (Oblimersen Sodium, Bcl-2 Antisense Oligonucleotide), Fludarabine and Rituximab in Previously Treated and Untreated Subjects with Chronic Lymphocytic Leukemia.

Blanche Mavromatis, MD, Kanti R. Rai, MD, Paul K. Wallace, PhD, Claudia Soho, OCN, Beverly Landrigan, RN, Patricia Meyn, RN, Tracey Wei, MS, Kenneth K. Chan, PhD, Philomena Casey, MS, Steven C. Novick, MD, PhD, Asher A. Chanan-Khan, MD
Journal: Blood
Blood (2005) 106 (11): 2129.
https://doi.org/10.1182/blood.V106.11.2129.2129
Published: 2005